WGRX
Wellgistics Health, Inc. Common Stock
NASDAQ: WGRX · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.11
-6.26% today
Updated 2026-04-29
Market cap
$14.57M
P/E ratio
—
P/S ratio
0.62x
EPS (TTM)
$-1.43
Dividend yield
—
52W range
$0 – $5
Volume
15.3M
Wellgistics Health, Inc. Common Stock (WGRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $32.78M | $0.00 | $18.13M | $23.34M |
| Revenue growth (YoY) | — | -100.0% | — | +28.7% |
| Cost of revenue | $27.03M | $0.00 | $16.36M | $32.98M |
| Gross profit | $5.75M | $0.00 | $1.77M | $-9.64M |
| Gross margin | 17.5% | — | 9.7% | -41.3% |
| R&D | $1400.00 | $375.00 | — | — |
| SG&A | $7.08M | $2.88M | $6.80M | $70.33M |
| Operating income | $-3.42M | $-2.88M | $-6.15M | $-81.19M |
| Operating margin | -10.4% | — | -33.9% | -347.9% |
| EBITDA | $-369034.00 | $-2.88M | $-4.91M | $-77.98M |
| EBITDA margin | -1.1% | — | -27.1% | -334.2% |
| EBIT | $-2.46M | — | $-6.02M | $-81.19M |
| Interest expense | $287183.00 | $15081.00 | $831467.00 | $4.58M |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.74M | $-2.90M | $-6.86M | $-101.27M |
| Net income growth (YoY) | — | -5.5% | -136.8% | -1377.1% |
| Profit margin | -8.4% | — | -37.8% | -433.9% |